Stable coronary artery disease (CAD) is a clinical entity of great epidemiological importance. It is becoming increasingly common due to the longer life expectancy, being strictly related to age and to advances in diagnostic techniques and pharmacological and non-pharmacological interventions. Stable CAD encompasses a variety of clinical and anatomic presentations, making the identification of its clinical and anatomical features challenging. Therapeutic interventions should be defined on an individual basis according to the patient's risk profile. To this aim, management flow charts have been reviewed based on sustainability and appropriateness derived from recent evidence. Special emphasis has been placed on non-pharmacological interventions, stressing the importance of lifestyle changes, including smoking cessation, regular physical activity, and diet. Adherence to therapy as an emerging risk factor is also discussed.
ANMCO/GICR-IACPR/SICI-GISE Consensus Document: The clinical management of chronic coronary artery disease / Riccio C.; Gulizia M.M.; Colivicchi F.; Di Lenarda A.; Musumeci G.; Faggiano P.M.; Abrignani M.G.; Rossini R.; Fattirolli F.; Valente S.; Mureddu G.F.; Temporelli P.L.; Olivari Z.; Amico A.F.; Casolo G.; Fresco C.; Menozzi A.; Nardi F.. - In: EUROPEAN HEART JOURNAL SUPPLEMENTS. - ISSN 1520-765X. - ELETTRONICO. - 19:(2017), pp. D163-D189. [10.1093/eurheartj/sux021]
ANMCO/GICR-IACPR/SICI-GISE Consensus Document: The clinical management of chronic coronary artery disease
Gulizia M. M.;Di Lenarda A.;Musumeci G.;Fattirolli F.;Valente S.;Casolo G.;Nardi F.
2017
Abstract
Stable coronary artery disease (CAD) is a clinical entity of great epidemiological importance. It is becoming increasingly common due to the longer life expectancy, being strictly related to age and to advances in diagnostic techniques and pharmacological and non-pharmacological interventions. Stable CAD encompasses a variety of clinical and anatomic presentations, making the identification of its clinical and anatomical features challenging. Therapeutic interventions should be defined on an individual basis according to the patient's risk profile. To this aim, management flow charts have been reviewed based on sustainability and appropriateness derived from recent evidence. Special emphasis has been placed on non-pharmacological interventions, stressing the importance of lifestyle changes, including smoking cessation, regular physical activity, and diet. Adherence to therapy as an emerging risk factor is also discussed.File | Dimensione | Formato | |
---|---|---|---|
Eur J Cardiol Suppl Chronic CHD.pdf
Accesso chiuso
Descrizione: articolo
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
677.7 kB
Formato
Adobe PDF
|
677.7 kB | Adobe PDF | Richiedi una copia |
Eur J Cardiol Suppl Chronic CHD.pdf
Accesso chiuso
Descrizione: articolo
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
677.7 kB
Formato
Adobe PDF
|
677.7 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.